<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04646473</url>
  </required_header>
  <id_info>
    <org_study_id>23559</org_study_id>
    <secondary_id>R01DK124428</secondary_id>
    <nct_id>NCT04646473</nct_id>
  </id_info>
  <brief_title>Sweetgoals for Type 1 Diabetes</brief_title>
  <official_title>Thinking Outside the Clinic: A Digital Health Approach for Young Adults With Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Trustees of Dartmouth College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Trustees of Dartmouth College</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will test an app and web-delivered intervention designed to improve glycemic&#xD;
      control (HbA1c) among young adults with Type 1 diabetes. All participants will receive the&#xD;
      &quot;core&quot; digital intervention, the SweetGoals app, focused on self-monitoring and goal setting.&#xD;
      Efficacy of two independent intervention components (incentives for adherence and web health&#xD;
      coaching) will be tested&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 29, 2021</start_date>
  <completion_date type="Anticipated">April 2025</completion_date>
  <primary_completion_date type="Anticipated">April 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1c</measure>
    <time_frame>+12 months</time_frame>
    <description>Mean HbA1c</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucose checking adherence</measure>
    <time_frame>+12 months</time_frame>
    <description>Mean proportion of days in the past 30 meeting daily glucose checking goal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Problem solving</measure>
    <time_frame>+12 months</time_frame>
    <description>Mean score on the Social Problem Solving Inventory-Revised</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>App only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sweetgoals app only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>App plus Incentives</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SweetGoals app + incentives=yes + coaching=no</description>
  </arm_group>
  <arm_group>
    <arm_group_label>App plus Coaching</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sweetgoals app + incentives=no + coaching=yes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>App plus Coaching plus Incentives</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sweetgoals app + incentives=yes + coaching=yes</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SweetGoals app</intervention_name>
    <description>App offers goal setting and feedback</description>
    <arm_group_label>App only</arm_group_label>
    <arm_group_label>App plus Coaching</arm_group_label>
    <arm_group_label>App plus Coaching plus Incentives</arm_group_label>
    <arm_group_label>App plus Incentives</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Coaching</intervention_name>
    <description>Web health coaching</description>
    <arm_group_label>App plus Coaching</arm_group_label>
    <arm_group_label>App plus Coaching plus Incentives</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Incentives</intervention_name>
    <description>Financial incentives for meeting goals</description>
    <arm_group_label>App plus Coaching plus Incentives</arm_group_label>
    <arm_group_label>App plus Incentives</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have a diagnosis of T1D for &gt;18 months&#xD;
&#xD;
          -  Have A1c â‰¥8.0%&#xD;
&#xD;
          -  Report a visit with physician managing type 1 diabetes (T1D) within the previous 6&#xD;
             months&#xD;
&#xD;
          -  Participants must use a glucometer or continuous glucose monitor compatible with&#xD;
             Glooko.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or breast feeding&#xD;
&#xD;
          -  Severe medical illness that would preclude participation (e.g., cystic fibrosis,&#xD;
             developmental disability, severe cognitive impairment)&#xD;
&#xD;
          -  Psychiatric illness that would preclude participation&#xD;
&#xD;
          -  Diabetes diagnoses other than T1D (Type 2 Diabetes, Maturity Onset Diabetes of the&#xD;
             Young/MODY)&#xD;
&#xD;
          -  Use of any medications known to impact glycemic control (oral or injectable&#xD;
             corticosteroids, beta-blockers, antipsychotic medications such as risperidone).&#xD;
&#xD;
          -  A history of known hemoglobinopathy, anemia, or transfusion (which could alter the&#xD;
             validity of HbA1c measurement)&#xD;
&#xD;
          -  Already being engaged in a psychological intervention targeting diabetes adherence.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine Stanger, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Trustees of Dartmouth College</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Catherine Stanger, Ph.D.</last_name>
    <phone>603-646-7023</phone>
    <email>catherine.stanger@dartmouth.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dartmouth College</name>
      <address>
        <city>Hanover</city>
        <state>New Hampshire</state>
        <zip>03755</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Stanger, Ph.D.</last_name>
      <phone>603-646-5109</phone>
      <email>catherine.stanger@dartmouth.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 16, 2020</study_first_submitted>
  <study_first_submitted_qc>November 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2020</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Trustees of Dartmouth College</investigator_affiliation>
    <investigator_full_name>Catherine Stanger</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be made available to other researchers and practitioners, while safeguarding the privacy of participants and protecting confidential and proprietary data and third-party intellectual property. Findings will be published as soon as they are available in relevant peer-reviewed journals that are available online, and share as requested directly to the author(s). Data requests can be made directly to the Principal Investigator with information for accessing the data on the NIDDK Data Repository.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>If the study ends and data are no longer being obtained directly from study participants by study investigators, all study data will be provided to the Repository by the end of the funding period (which may include no-cost extensions). The period of exclusive use of the entire dataset from the study will be for three years after the last study contact for collection of intervention outcomes.</ipd_time_frame>
    <ipd_access_criteria>Data requests made directly to the Principal Investigator or through the NIDDK Data Repository</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

